Literature DB >> 7441940

Farber's lipogranulomatosis: ceramidase deficiency and prolonged survival in three relatives.

L Pavone, H W Moser, F Mollica, C Reitano, P Durand.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7441940

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN: 0021-7263


× No keyword cloud information.
  7 in total

Review 1.  Farber disease: an ultrastructural study. Report of a case and review of the literature.

Authors:  L Zappatini-Tommasi; C Dumontel; P Guibaud; C Girod
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Farber disease with prolonged survival.

Authors:  A Fiumara; F Nigro; L Pavone; H W Moser
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  Farber's disease in two siblings, sural nerve and subcutaneous biopsies by light and electron microscopy.

Authors:  J F Pellissier; M Berard-Badier; N Pinsard
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

4.  A case of lipogranulomatosis Farber: some clinical and ultrastructural aspects.

Authors:  U Burck; H W Moser; H H Goebel; R Grüttner; K R Held
Journal:  Eur J Pediatr       Date:  1985-01       Impact factor: 3.183

5.  Farber disease: clinical presentation, pathogenesis and a new approach to treatment.

Authors:  Karoline Ehlert; Michael Frosch; Natalja Fehse; Axel Zander; Johannes Roth; Josef Vormoor
Journal:  Pediatr Rheumatol Online J       Date:  2007-06-29       Impact factor: 3.054

Review 6.  Acid ceramidase deficiency: Farber disease and SMA-PME.

Authors:  Fabian P S Yu; Samuel Amintas; Thierry Levade; Jeffrey A Medin
Journal:  Orphanet J Rare Dis       Date:  2018-07-20       Impact factor: 4.123

Review 7.  Lipid Involvement in Neurodegenerative Diseases of the Motor System: Insights from Lysosomal Storage Diseases.

Authors:  James C Dodge
Journal:  Front Mol Neurosci       Date:  2017-11-03       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.